New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
08:37 EDTELGXEndologix investors should add to positions, says Canaccord
Canaccord recommends investors add to positions in Endologix following investor meetings with management. The firm believes top line growth will accelerate in the second half of the year and that Nellix will make it one of the most compelling long-term growth stories in addition to making it an attractive takeover target. Shares are Buy rated with a $17.50 price target.
News For ELGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ELGX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use